BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Staging
3 results:

  • 1. High-risk features in potentially resectable colon cancer: a prospective MDCT-pathology agreement study.
    Santiago IA; Rodrigues ER; Germano AS; Costa AM; Manso RT; Gomes AP; Leichsenring CD; Geraldes VM
    Abdom Radiol (NY); 2016 Oct; 41(10):1877-90. PubMed ID: 27315073
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.
    Croner RS; Geppert CI; Bader FG; Nitsche U; Späth C; Rosenberg R; Zettl A; Matias-Guiu X; Tarragona J; Güller U; Stürzl M; Zuber M
    Br J Cancer; 2014 May; 110(10):2544-50. PubMed ID: 24722182
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery.
    Lee JC; Wang ST; Chow NH; Yang HB
    Eur J Cancer; 2002 May; 38(8):1065-71. PubMed ID: 12008194
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.